Oculis Holding AG
Privosegtor
optic neuritis
Resolved
463days ago
Advisory committee · ~ Mar 31, 2025 estimated
What's at stake
An FDA advisory committee reviews Privosegtor for optic neuritis around ~ Mar 31, 2025. The panel's public vote often front-runs the agency's final verdict — and the share price.
Primary source
· SEC 6-K
verified 12h ago
“Special Protocol Assessment (SPA) agreement received from the FDA regarding the design of the PIONEER-1 registrational trial of Privosegtor in ON.”